...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of a New System, VITEK 2, for Identification and Antimicrobial Susceptibility Testing of Enterococci
【24h】

Evaluation of a New System, VITEK 2, for Identification and Antimicrobial Susceptibility Testing of Enterococci

机译:评估用于鉴定和鉴定肠球菌的新系统VITEK 2

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We evaluated the new automated VITEK 2 system (bioMérieux) for the identification and antimicrobial susceptibility testing of enterococci. The results obtained with the VITEK 2 system were compared to those obtained by reference methods: standard identification by the scheme of Facklam and Sahm [R. R. Facklam and D. F. Sahm, p. 308–314, in P. R. Murray et al., ed., Manual of Clinical Microbiology, 6th ed., 1995] and with the API 20 STREP system and, for antimicrobial susceptibility testing, broth microdilution and agar dilution methods by the procedures of the National Committee for Clinical Laboratory Standards. The presence ofvanA and vanB genes was determined by PCR. A total of 150 clinical isolates were studied, corresponding to 60Enterococcus faecalis, 55 Enterococcus faecium, 26 Enterococcus gallinarum, 5 Enterococcus avium, 2 Enterococcus durans, and 2Enterococcus raffinosus isolates. Among those isolates, 131 (87%) were correctly identified to the species level with the VITEK 2 system. Approximately half of the misidentifications were for E. faecium with low-level resistance to vancomycin, identified asE. gallinarum or E. casseliflavus; however, a motility test solved the discrepancies and increased the agreement to 94%. Among the strains studied, 66% were vancomycin resistant (57 VanA, 16 VanB, and 26 VanC strains), 23% were ampicillin resistant (MICs, ≥16 μg/ml), 31% were high-level gentamicin resistant, and 45% were high-level streptomycin resistant. Percentages of agreement for susceptibility and resistance to ampicillin, vancomycin, and teicoplanin and for high-level gentamicin resistance and high-level streptomycin resistance were 93, 95, 97, 97, and 96%, respectively. The accuracy of identification and antimicrobial susceptibility testing of enterococci with the VITEK 2 system, together with the significant reduction in handling time, will have a positive impact on the work flow of the clinical microbiology laboratory.
机译:我们评估了新的自动化VITEK 2系统(bioMérieux),以鉴定和鉴定肠球菌。用VITEK 2系统获得的结果与通过参考方法获得的结果进行了比较:通过Facklam和Sahm [R. R. Facklam和D.F. Sahm,第1页。 308–314, in PR Murray等编辑,《临床微生物学手册》 ,第6版,1995年],并带有API 20 STREP系统,以及用于抗菌剂按照国家临床实验室标准委员会的程序进行药敏试验,肉汤微量稀释和琼脂稀释法。通过PCR确定 vanA vanB 基因的存在。共研究了150株临床分离株,分别对应于60株粪肠球菌,55株粪肠球菌,26株鸡肠球菌,5株肠球菌。 ,2个杜伦肠球菌和2个棉球肠球菌分离株。在这些分离物中,使用VITEK 2系统正确鉴定了131种(87%)的菌种。大约一半的错误标识是针对 E的。对万古霉素耐药的粪便,被鉴定为 E。 gallinarum E。 casseliflavus ;但是,通过运动测试解决了差异,并将一致性提高到94%。在研究的菌株中,有66%对万古霉素耐药(57 VanA,16 VanB和26 VanC菌株),23%对氨苄西林耐药(MIC,≥16μg/ ml),31%对高水平庆大霉素耐药和45%具有高水平的链霉素抗性。对氨苄西林,万古霉素和替考拉宁的敏感性和耐药性以及对庆大霉素的高水平耐药和对链霉素的高水平耐药的一致性百分比分别为93%,95%,97%,97%和96%。使用VITEK 2系统对肠球菌进行鉴定和抗菌药敏试验的准确性,以及处理时间的显着减少,将对临床微生物学实验室的工作流程产生积极影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号